Ratings by Benchmark (Bruce D. Jackson)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/3/2026 | Belite Bio, Inc, ADR | BLTE | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2026 | Abbott Labs | ABT | Maintain | Buy (Buy) |
|
Details | ||
| 1/21/2026 | Humacyte | HUMA | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2025 | Belite Bio, Inc, ADR | BLTE | Maintain | Buy (Buy) |
|
Details | ||
| 11/21/2025 | Abbott Labs | ABT | Maintain | Buy (Buy) |
|
Details | ||
| 11/13/2025 | Humacyte | HUMA | Maintain | Buy (Buy) |
|
Details | ||
| 10/31/2025 | Belite Bio, Inc, ADR | BLTE | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2025 | Belite Bio, Inc, ADR | BLTE | Maintain | Buy (Buy) |
|
Details | ||
| 8/12/2025 | Humacyte | HUMA | Maintain | Buy (Buy) |
|
Details | ||
| 8/12/2025 | Belite Bio, Inc, ADR | BLTE | Maintain | Buy (Buy) |
|
Details | ||
| 5/22/2025 | Belite Bio, Inc, ADR | BLTE | Maintain | Buy (Buy) |
|
Details | ||
| 5/15/2025 | Belite Bio, Inc, ADR | BLTE | Maintain | Buy (Buy) |
|
Details | ||
| 5/14/2025 | Humacyte | HUMA | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2025 | Genelux Corp. | GNLX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 4/8/2025 | Genelux Corp. | GNLX | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 3/31/2025 | Humacyte | HUMA | Maintain | Buy (Buy) |
|
Details | ||
| 3/26/2025 | Genelux Corp. | GNLX | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 3/26/2025 | Belite Bio, Inc, ADR | BLTE | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2025 | Humacyte | HUMA | Maintain | Buy (Buy) |
|
Details | ||
| 1/21/2025 | Belite Bio, Inc, ADR | BLTE | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2024 | Humacyte | HUMA | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2024 | Biolase | BIOL | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 9/5/2024 | Humacyte | HUMA | Maintain | Buy (Buy) |
|
Details | ||
| 5/31/2024 | Genelux Corp. | GNLX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 3/22/2024 | Biolase | BIOL | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2023 | Genelux Corp. | GNLX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 9/20/2023 | Biolase | BIOL | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 6/9/2023 | Genelux Corp. | GNLX | Maintain | Buy (N/A) |
|
Details | ||
| 5/25/2023 | Biolase | BIOL | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 7/1/2022 | Belite Bio, Inc, ADR | BLTE | New Coverage | Buy (N/A) |
31.14 (173.30) |
456.52% | Details |
